Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other financing activities (2019 - 2024)

Historic Other financing activities for Dna X (SONM) over the last 4 years, with Q2 2024 value amounting to $472000.0.

  • Dna X's Other financing activities rose 3184.36% to $472000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $1.5 million, marking a year-over-year decrease of 2554.71%. This contributed to the annual value of $1.5 million for FY2023, which is 354.61% down from last year.
  • Latest data reveals that Dna X reported Other financing activities of $472000.0 as of Q2 2024, which was up 3184.36% from $324000.0 recorded in Q1 2024.
  • Dna X's Other financing activities' 5-year high stood at $1.0 million during Q4 2022, with a 5-year trough of $253000.0 in Q1 2022.
  • For the 3-year period, Dna X's Other financing activities averaged around $430571.4, with its median value being $324000.0 (2024).
  • Data for Dna X's Other financing activities shows a peak YoY increase of 3184.36% (in 2024) and a maximum YoY decrease of 485.44% (in 2024) over the last 5 years.
  • Dna X's Other financing activities (Quarter) stood at $1.0 million in 2022, then plummeted by 65.48% to $358000.0 in 2023, then soared by 31.84% to $472000.0 in 2024.
  • Its Other financing activities stands at $472000.0 for Q2 2024, versus $324000.0 for Q1 2024 and $358000.0 for Q2 2023.